Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Elevated aromatase expression correlates with cervical carcinoma progression.

Veerapaneni P, Kirma N, Nair HB, Hammes LS, Hall KL, Tekmal RR.

Gynecol Oncol. 2009 Sep;114(3):496-500. doi: 10.1016/j.ygyno.2009.05.041. Epub 2009 Jun 24.

PMID:
19555998
2.

Up-regulation of VEGF, c-fms and COX-2 expression correlates with severity of cervical cancer precursor (CIN) lesions and invasive disease.

Hammes LS, Tekmal RR, Naud P, Edelweiss MI, Kirma N, Valente PT, Syrjänen KJ, Cunha-Filho JS.

Gynecol Oncol. 2008 Sep;110(3):445-51. doi: 10.1016/j.ygyno.2008.04.038. Epub 2008 Jun 20.

PMID:
18565574
3.

Activin A increases invasiveness of endometrial cells in an in vitro model of human peritoneum.

Ferreira MC, Witz CA, Hammes LS, Kirma N, Petraglia F, Schenken RS, Reis FM.

Mol Hum Reprod. 2008 May;14(5):301-7. doi: 10.1093/molehr/gan016. Epub 2008 Mar 21.

PMID:
18359784
4.

Computer-assisted immunohistochemical analysis of cervical cancer biomarkers using low-cost and simple software.

Hammes LS, Korte JE, Tekmal RR, Naud P, Edelweiss MI, Valente PT, Longatto-Filho A, Kirma N, Cunha-Filho JS.

Appl Immunohistochem Mol Morphol. 2007 Dec;15(4):456-62.

PMID:
18091391
5.

HER-2/neu x aromatase double transgenic mice model: the effects of aromatase overexpression on mammary tumorigenesis.

Tekmal RR, Nair HB, Perla RP, Kirma N.

J Steroid Biochem Mol Biol. 2007 Aug-Sep;106(1-5):111-8. Epub 2007 May 24.

6.
7.

Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression--clinicopathological correlation.

Hammes LS, Tekmal RR, Naud P, Edelweiss MI, Kirma N, Valente PT, Syrjänen KJ, Cunha-Filho JS.

Gynecol Oncol. 2007 Apr;105(1):157-65. Epub 2007 Jan 16.

PMID:
17229459
8.

Inhibition of estrogen-induced mammary tumor formation in MMTV-aromatase transgenic mice by 4-chlorophenylacetate.

Sidell N, Kirma N, Morgan ET, Nair H, Tekmal RR.

Cancer Lett. 2007 Jun 28;251(2):302-10. Epub 2007 Jan 9.

9.

Induction of aromatase expression in cervical carcinomas: effects of endogenous estrogen on cervical cancer cell proliferation.

Nair HB, Luthra R, Kirma N, Liu YG, Flowers L, Evans D, Tekmal RR.

Cancer Res. 2005 Dec 1;65(23):11164-73.

10.

Estrogen receptor alpha is required for mammary development and the induction of mammary hyperplasia and epigenetic alterations in the aromatase transgenic mice.

Tekmal RR, Liu YG, Nair HB, Jones J, Perla RP, Lubahn DB, Korach KS, Kirma N.

J Steroid Biochem Mol Biol. 2005 May;95(1-5):9-15.

PMID:
15955696
11.
12.

Characterization of six type A strains of Clostridium botulinum that contain type B toxin gene sequences.

Kirma N, Ferreira JL, Baumstark BR.

FEMS Microbiol Lett. 2004 Feb 16;231(2):159-64.

13.

Use of letrozole as a chemopreventive agent in aromatase overexpressing transgenic mice.

Luthra R, Kirma N, Jones J, Tekmal RR.

J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):461-7.

PMID:
14623545
14.

Anti-aromatase chemicals in red wine.

Eng ET, Williams D, Mandava U, Kirma N, Tekmal RR, Chen S.

Ann N Y Acad Sci. 2002 Jun;963:239-46.

PMID:
12095950
16.
17.
18.

Suppression of aromatase (estrogen synthetase) by red wine phytochemicals.

Eng ET, Williams D, Mandava U, Kirma N, Tekmal RR, Chen S.

Breast Cancer Res Treat. 2001 May;67(2):133-46.

PMID:
11519862
19.

Acceleration of mammary neoplasia in aromatase transgenic mice by 7,12-dimethylbenz[a]anthracene.

Keshava N, Mandava U, Kirma N, Tekmal RR.

Cancer Lett. 2001 Jun 26;167(2):125-33.

PMID:
11369132
20.

Supplemental Content

Loading ...
Support Center